5
Participants
Start Date
September 24, 2020
Primary Completion Date
November 23, 2020
Study Completion Date
November 23, 2020
GSK3640254 Oral tablet
GSK3640254 will be available as white film-coated round tablets to be administered via oral route with meal in the morning with 240 milliliter (mL) of water at room temperature.
[14C]-GSK3640254 intravenous infusion
\[14C\]-GSK3640254 will be available as clear, colorless solution free from visible particulates to be administered via the IV route.
[14C]-GSK3640254 powder
\[14C\]-GSK3640254 will be available as white powder to be reconstituted into a suspension with 25 mL of vehicle before dosing so as to administer 85 mg dose with meal in the morning.
GSK Investigational Site, London
Lead Sponsor
ViiV Healthcare
INDUSTRY